nach oben

Seminars in Immunopathology

Erschienen in:

01.03.2011 | Review

Inflammation and transplantation tolerance

verfasst von: Daniel R. Goldstein

Erschienen in: Seminars in Immunopathology | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Although our understanding of the immunological mechanisms of transplant tolerance induction has greatly improved, how the innate immune system impacts transplant tolerance has only been recently appreciated. In this review, the involvement of the innate immune receptors, Toll-like receptors (TLRs), in both experimental models of acute allograft rejection and transplant tolerance induction in addition to clinical studies of organ transplantation are described. Several inflammatory cytokines, including IL-6, TNF-α, and type I interferons, which are induced by TLRs and other activators of innate immunity, prevent transplant tolerance induction. Their induction may be provoked by environmental exposures, such as viral or bacterial infections. Further investigation as to the innate inflammatory basis that controls the balance between immune acceptance and allograft rejection may lead us closer to the elusive goal of transplant tolerance acquisition.

Wekerle T, Kurtz J, Bigenzahn S, Takeuchi Y, Sykes M (2002) Mechanisms of transplant tolerance induction using costimulatory blockade. Curr Opin Immunol 14:592–600PubMedCrossRef

Walsh PT, Taylor DK, Turka LA (2004) Tregs and transplantation tolerance. J Clin Invest 114:1398–1403PubMed

Dai Z, Lakkis FG (1999) The role of cytokines, CTLA-4 and costimulation in transplant tolerance and rejection. Curr Opin Immunol 11:504–508PubMedCrossRef

Brook MO, Wood KJ, Jones ND (2006) The impact of memory T cells on rejection and the induction of tolerance. Transplantation 82:1–9PubMedCrossRef

Adams AB, Williams MA, Jones TR, Shirasugi N, Durham MM, Kaech SM et al (2003) Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 111:1887–1895PubMed

Selin LK, Brehm MA, Naumov YN, Cornberg M, Kim S-K, Clute SC et al (2006) Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity. Immunol Rev 211:164–181PubMedCrossRef

Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783PubMedCrossRef

Shirali A, Goldstein D (2008) Tracking the toll of kidney disease. J Am Soc Nephrol 19:1444–1450PubMedCrossRef

Taro Kawai SA (2008) Toll-like receptor and RIG-1-like receptor signaling. Ann NY Acad Sci 1143:1–20PubMedCrossRef

10.

Fritz JH, Ferrero RL, Philpott DJ, Girardin SE (2006) Nod-like proteins in immunity, inflammation and disease. Nat Immunol 7:1250–1257PubMedCrossRef

11.

Dalod M, Salazar-Mather TP, Malmgaard L, Lewis C, Asselin-Paturel C, Briere F et al (2002) Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J Exp Med 195:517–528PubMedCrossRef

12.

Kawai T, Akira S (2007) SnapShot: pattern-recognition receptors. Cell 129:1024.e1021–1024.e1022CrossRef

13.

Goldstein DR, Tesar BM, Akira S, Lakkis FG (2003) Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 111:1571–1578PubMed

14.

Tesar BM, Zhang J, Li Q, Goldstein DR (2004) TH1 immune responses to fully mhc mismatched allografts are diminished in the absence of Myd88, a toll-like receptor signal adaptor protein. Am J Transplant 4:1429–1439PubMedCrossRef

15.

Goldberg A, Parolini M, Chin BY, Czismadia E, Otterbein LE, Bach FH et al (2007) Toll-like receptor 4 suppression leads to islet allograft survival. FASEB J 21:2840–2848PubMedCrossRef

16.

Palmer SM, Burch LH, Davis RD, Herczyk WF, Howell DN, Reinsmoen NL et al (2003) The role of innate immunity in acute allograft rejection after lung transplantation. Am J Respir Crit Care Med 168:628–632PubMedCrossRef

17.

Ducloux D, Deschamps M, Yannaraki M, Ferrand C, Bamoulid J, Saas P et al (2005) Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 67:2454–2461PubMedCrossRef

18.

Kruger B, Krick S, Dhillon N, Lerner SM, Ames S, Bromberg JS et al (2009) Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci 106:3390–3395PubMedCrossRef

19.

Goldstein DR (2007) The identity of innate immune activators in organ transplantation: origins from within or exterior to the host? Am J Transplant 7:1692–1694PubMedCrossRef

20.

Shirali A, Goldstein DR (2008) Activation of the innate immune system by the endogenous ligand hyaluronan. Curr Opin Organ Transpl 13:20–25CrossRef

21.

Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T et al (2002) Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195:99–111PubMedCrossRef

22.

Tesar BM, Jiang D, Liang J, Palmer SM, Noble PW, Goldstein DR (2006) The role of hyaluronan degradation products as innate alloimmune agonists. Am J Transplant 6:2622–2635PubMedCrossRef

23.

Johnson GB, Brunn GJ, Platt JL (2004) Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through toll-like receptor 4. J Immunol 172:20–24PubMed

24.

Smiley ST, King JA, Hancock WW (2001) Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J Immunol 167:2887–2894PubMed

25.

Shi Y, Evans J, Rock K (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516–521PubMedCrossRef

26.

Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT et al (2005) The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201:1135–1143PubMedCrossRef

27.

Jang HR, Rabb H (2009) The innate immune response in ischemic acute kidney injury. Clin Immunol 130:41–50PubMedCrossRef

28.

Rouschop KMA, Roelofs JJTH, Claessen N, Martins PdC, Zwaginga J-J, Pals ST et al (2005) Protection against renal ischemia reperfusion injury by CD44 disruption. J Am Soc Nephrol 16:2034–2043PubMedCrossRef

29.

Shishido T, Nozaki N, Yamaguchi S, Shibata Y, Nitobe J, Miyamoto T et al (2003) Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 108:2905–2910PubMedCrossRef

30.

Balistreri CR, Candore G, Colonna-Romano G, Lio D, Caruso M, Hoffmann E et al (2004) Role of toll-like receptor 4 in acute myocardial infarction and longevity. JAMA 292:2339–2340, %R 101001/jama292192339PubMedCrossRef

31.

Edfeldt K, Bennet AM, Eriksson P, Frostegard J, Wiman B, Hamsten A et al (2004) Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur Heart J 25:1447–1453PubMedCrossRef

32.

Walker WE, Nasr IW, Camirand G, Tesar BM, Booth CJ, Goldstein DR (2006) Absence of innate MyD88 signaling promotes inducible allograft acceptance. J Immunol 177:5307–5316PubMed

33.

Braudeau C, Ashton-Chess J, Giral M, Dugas ELS, Pallier A, Braud C et al (2008) Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients. Transplantation 86:130–136PubMedCrossRef

34.

Sutmuller RPM, den Brok MHMGM, Kramer M, Bennink EJ, Toonen LWJ, Kullberg B-J et al (2006) Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 116:485–494PubMedCrossRef

35.

Kubo T, Hatton RD, Oliver J, Liu X, Elson CO, Weaver CT (2004) Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells. J Immunol 173:7249–7258PubMed

36.

Liu H, Komai-Koma M, Xu D, Liew FY (2006) Toll-like receptor 2 signaling modulates the functions of CD4 + CD25+ regulatory T cells. Proc Natl Acad Sci 103:7048–7053PubMedCrossRef

37.

Pasare C, Medzhitov R (2003) Toll pathway-dependent blockade of CD4 + CD25+ T cell-mediated suppression by dendritic cells. Science 299:1033–1036PubMedCrossRef

38.

Chen L, Wang T, Zhou P, Ma L, Yin D, Shen J et al (2006) TLR engagement prevents transplantation tolerance. Am J Transplant 6:2282–2291PubMedCrossRef

39.

Thornley TB, Brehm MA, Markees TG, Shultz LD, Mordes JP, Welsh RM et al (2006) TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts. J Immunol 176:1561–1570PubMed

40.

Konieczny BT, Dai Z, Elwood ET, Saleem S, Linsley PS, Baddoura FK et al (1998) IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 160:2059–2064PubMed

41.

Dai Z, Konieczny BT, Lakkis FG (2000) The dual role of IL-2 in the generation and maintenance of CD8+ memory T cells. J Immunol 165:3031–3036PubMed

42.

Samoilova EB, Horton JL, Hilliard B, Liu T-ST, Chen Y (1998) IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of il-6 in the activation and differentiation of autoreactive T cells. J Immunol 161:6480–6486PubMed

43.

Hata H, Sakaguchi N, Yoshitomi H, Iwakura Y, Sekikawa K, Azuma Y et al (2004) Distinct contribution of IL-6, TNF-{alpha}, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 114:582–588PubMed

44.

Shen H, Goldstein DR (2009) IL-6 and TNF-{alpha} synergistically inhibit allograft acceptance. J Am Soc Nephrol 5:1032–1040CrossRef

45.

Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, Mirtsos C et al (2002) Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416:750–756PubMedCrossRef

46.

Liu YJ (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23:275–306PubMedCrossRef

47.

Thornley TB, Phillips NE, Beaudette-Zlatanova BC, Markees TG, Bahl K, Brehm MA et al (2007) Type 1 IFN mediates cross-talk between innate and adaptive immunity that abrogates transplantation tolerance. J Immunol 179:6620–6629PubMed

48.

Wang T, Chen L, Ahmed E, Ma L, Yin D, Zhou P et al (2008) Prevention of allograft tolerance by bacterial infection with Listeria monocytogenes. J Immunol 180:5991–5999PubMed

49.

Vilchez RA, McCurry K, Dauber J, Lacono A, Griffith B, Fung J et al (2002) Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2:287–291PubMedCrossRef

50.

Soderberg-Naucler C, Emery VC (2001) Viral infections and their impact on chronic renal allograft dysfunction. Transplantation 71:SS24–SS30PubMed

51.

Koskinen PK, Kallio EA, Tikkanen JM, Sihvola RK, Hayry PJ, Lemstrom KB (1999) Cytomegalovirus infection and cardiac allograft vasculopathy. Transpl Infect Dis 1:115–126PubMedCrossRef

52.

Gabriel R, Selwyn S, Brown D, Crossland JM, Loughridge LW, Morgan MN et al (1976) Virus infections and acute renal transplant rejection. Nephron 16:282–286PubMedCrossRef

53.

Weaver CT, Murphy KM (2007) The central role of the Th17 lineage in regulating the inflammatory/autoimmune axis. Semin Immunol 19:351–352PubMedCrossRef

54.

Weaver CT, Hatton RD, Mangan PR, Harrington LE (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25:821–852PubMedCrossRef

55.

Burrell BE, Csencsits K, Lu G, Grabauskiene S, Bishop BK (2008) CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice. J Immunol 181:3906–3914PubMed

56.

Yuan X, Ansari MJ, D’Addio F, Paez-Cortez J, Schmitt I, Donnarumma M et al (2009) Targeting Tim-1 to overcome resistance to transplantation tolerance mediated by CD8 T17 cells. Proc Natl Acad Sci 106:10734–10739PubMedCrossRef

Titel: Inflammation and transplantation tolerance
verfasst von: Daniel R. Goldstein
Publikationsdatum: 01.03.2011
Verlag: Springer-Verlag
Erschienen in: Seminars in Immunopathology / Ausgabe 2/2011
Print ISSN: 1863-2297
Elektronische ISSN: 1863-2300
DOI: https://doi.org/10.1007/s00281-011-0251-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2011

Advances of genomic science and systems biology in renal transplantation: a review

Special issues in the management and selection of the donor for lung transplantation

Role of Th17 cells and IL-17 in lung transplant rejection

Steroids in kidney transplant patients

Loss of tolerance to self after transplant